AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of overall survival in a ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study ...

‘Three years earlier provides time for intervention,’ the lead researcher says of the early detection test. Mr. Curl covered ...

A new hereditary condition has been discovered that affects patients' ability to repair DNA – leaving them both at greater ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially ...

AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...

Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years ...

England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer ...

NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.

Researchers detected cancer-linked genetic mutations in blood samples taken over three years before diagnosis. In a ...